A New Era of Neuro-Oncology Research Pioneered by Multi-Omics Analysis and Machine Learning

Although the incidence of central nervous system (CNS) cancers is not high, it significantly reduces a patient’s quality of life and results in high mortality rates. A low incidence also means a low number of cases, which in turn means a low amount of information. To compensate, researchers have tri...

Full description

Bibliographic Details
Main Authors: Satoshi Takahashi, Masamichi Takahashi, Shota Tanaka, Shunsaku Takayanagi, Hirokazu Takami, Erika Yamazawa, Shohei Nambu, Mototaka Miyake, Kaishi Satomi, Koichi Ichimura, Yoshitaka Narita, Ryuji Hamamoto
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/11/4/565
_version_ 1797537956883333120
author Satoshi Takahashi
Masamichi Takahashi
Shota Tanaka
Shunsaku Takayanagi
Hirokazu Takami
Erika Yamazawa
Shohei Nambu
Mototaka Miyake
Kaishi Satomi
Koichi Ichimura
Yoshitaka Narita
Ryuji Hamamoto
author_facet Satoshi Takahashi
Masamichi Takahashi
Shota Tanaka
Shunsaku Takayanagi
Hirokazu Takami
Erika Yamazawa
Shohei Nambu
Mototaka Miyake
Kaishi Satomi
Koichi Ichimura
Yoshitaka Narita
Ryuji Hamamoto
author_sort Satoshi Takahashi
collection DOAJ
description Although the incidence of central nervous system (CNS) cancers is not high, it significantly reduces a patient’s quality of life and results in high mortality rates. A low incidence also means a low number of cases, which in turn means a low amount of information. To compensate, researchers have tried to increase the amount of information available from a single test using high-throughput technologies. This approach, referred to as single-omics analysis, has only been partially successful as one type of data may not be able to appropriately describe all the characteristics of a tumor. It is presently unclear what type of data can describe a particular clinical situation. One way to solve this problem is to use multi-omics data. When using many types of data, a selected data type or a combination of them may effectively resolve a clinical question. Hence, we conducted a comprehensive survey of papers in the field of neuro-oncology that used multi-omics data for analysis and found that most of the papers utilized machine learning techniques. This fact shows that it is useful to utilize machine learning techniques in multi-omics analysis. In this review, we discuss the current status of multi-omics analysis in the field of neuro-oncology and the importance of using machine learning techniques.
first_indexed 2024-03-10T12:24:33Z
format Article
id doaj.art-e0cab93e2509473cbceb9bcf24ef6c86
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-10T12:24:33Z
publishDate 2021-04-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-e0cab93e2509473cbceb9bcf24ef6c862023-11-21T15:14:15ZengMDPI AGBiomolecules2218-273X2021-04-0111456510.3390/biom11040565A New Era of Neuro-Oncology Research Pioneered by Multi-Omics Analysis and Machine LearningSatoshi Takahashi0Masamichi Takahashi1Shota Tanaka2Shunsaku Takayanagi3Hirokazu Takami4Erika Yamazawa5Shohei Nambu6Mototaka Miyake7Kaishi Satomi8Koichi Ichimura9Yoshitaka Narita10Ryuji Hamamoto11Division of Medical AI Research and Development, National Cancer Center Research Institute, Tokyo 104-0045, JapanDepartment of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo 104-0045, JapanDepartment of Neurosurgery, Faculty of Medicine, The University of Tokyo, Tokyo 113-8655, JapanDepartment of Neurosurgery, Faculty of Medicine, The University of Tokyo, Tokyo 113-8655, JapanDepartment of Neurosurgery, Faculty of Medicine, The University of Tokyo, Tokyo 113-8655, JapanDepartment of Neurosurgery, Faculty of Medicine, The University of Tokyo, Tokyo 113-8655, JapanDepartment of Neurosurgery, Faculty of Medicine, The University of Tokyo, Tokyo 113-8655, JapanDepartment of Diagnostic Radiology, National Cancer Center Hospital, Tokyo 104-0045, JapanDepartment of Diagnostic Pathology, National Cancer Center Hospital, Tokyo 104-0045, JapanDivision of Brain Tumor Translational Research, National Cancer Center Research Institute, Tokyo 104-0045, JapanDepartment of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo 104-0045, JapanDivision of Medical AI Research and Development, National Cancer Center Research Institute, Tokyo 104-0045, JapanAlthough the incidence of central nervous system (CNS) cancers is not high, it significantly reduces a patient’s quality of life and results in high mortality rates. A low incidence also means a low number of cases, which in turn means a low amount of information. To compensate, researchers have tried to increase the amount of information available from a single test using high-throughput technologies. This approach, referred to as single-omics analysis, has only been partially successful as one type of data may not be able to appropriately describe all the characteristics of a tumor. It is presently unclear what type of data can describe a particular clinical situation. One way to solve this problem is to use multi-omics data. When using many types of data, a selected data type or a combination of them may effectively resolve a clinical question. Hence, we conducted a comprehensive survey of papers in the field of neuro-oncology that used multi-omics data for analysis and found that most of the papers utilized machine learning techniques. This fact shows that it is useful to utilize machine learning techniques in multi-omics analysis. In this review, we discuss the current status of multi-omics analysis in the field of neuro-oncology and the importance of using machine learning techniques.https://www.mdpi.com/2218-273X/11/4/565multi-omics analysismachine learningneuro-oncologyglioma
spellingShingle Satoshi Takahashi
Masamichi Takahashi
Shota Tanaka
Shunsaku Takayanagi
Hirokazu Takami
Erika Yamazawa
Shohei Nambu
Mototaka Miyake
Kaishi Satomi
Koichi Ichimura
Yoshitaka Narita
Ryuji Hamamoto
A New Era of Neuro-Oncology Research Pioneered by Multi-Omics Analysis and Machine Learning
Biomolecules
multi-omics analysis
machine learning
neuro-oncology
glioma
title A New Era of Neuro-Oncology Research Pioneered by Multi-Omics Analysis and Machine Learning
title_full A New Era of Neuro-Oncology Research Pioneered by Multi-Omics Analysis and Machine Learning
title_fullStr A New Era of Neuro-Oncology Research Pioneered by Multi-Omics Analysis and Machine Learning
title_full_unstemmed A New Era of Neuro-Oncology Research Pioneered by Multi-Omics Analysis and Machine Learning
title_short A New Era of Neuro-Oncology Research Pioneered by Multi-Omics Analysis and Machine Learning
title_sort new era of neuro oncology research pioneered by multi omics analysis and machine learning
topic multi-omics analysis
machine learning
neuro-oncology
glioma
url https://www.mdpi.com/2218-273X/11/4/565
work_keys_str_mv AT satoshitakahashi aneweraofneurooncologyresearchpioneeredbymultiomicsanalysisandmachinelearning
AT masamichitakahashi aneweraofneurooncologyresearchpioneeredbymultiomicsanalysisandmachinelearning
AT shotatanaka aneweraofneurooncologyresearchpioneeredbymultiomicsanalysisandmachinelearning
AT shunsakutakayanagi aneweraofneurooncologyresearchpioneeredbymultiomicsanalysisandmachinelearning
AT hirokazutakami aneweraofneurooncologyresearchpioneeredbymultiomicsanalysisandmachinelearning
AT erikayamazawa aneweraofneurooncologyresearchpioneeredbymultiomicsanalysisandmachinelearning
AT shoheinambu aneweraofneurooncologyresearchpioneeredbymultiomicsanalysisandmachinelearning
AT mototakamiyake aneweraofneurooncologyresearchpioneeredbymultiomicsanalysisandmachinelearning
AT kaishisatomi aneweraofneurooncologyresearchpioneeredbymultiomicsanalysisandmachinelearning
AT koichiichimura aneweraofneurooncologyresearchpioneeredbymultiomicsanalysisandmachinelearning
AT yoshitakanarita aneweraofneurooncologyresearchpioneeredbymultiomicsanalysisandmachinelearning
AT ryujihamamoto aneweraofneurooncologyresearchpioneeredbymultiomicsanalysisandmachinelearning
AT satoshitakahashi neweraofneurooncologyresearchpioneeredbymultiomicsanalysisandmachinelearning
AT masamichitakahashi neweraofneurooncologyresearchpioneeredbymultiomicsanalysisandmachinelearning
AT shotatanaka neweraofneurooncologyresearchpioneeredbymultiomicsanalysisandmachinelearning
AT shunsakutakayanagi neweraofneurooncologyresearchpioneeredbymultiomicsanalysisandmachinelearning
AT hirokazutakami neweraofneurooncologyresearchpioneeredbymultiomicsanalysisandmachinelearning
AT erikayamazawa neweraofneurooncologyresearchpioneeredbymultiomicsanalysisandmachinelearning
AT shoheinambu neweraofneurooncologyresearchpioneeredbymultiomicsanalysisandmachinelearning
AT mototakamiyake neweraofneurooncologyresearchpioneeredbymultiomicsanalysisandmachinelearning
AT kaishisatomi neweraofneurooncologyresearchpioneeredbymultiomicsanalysisandmachinelearning
AT koichiichimura neweraofneurooncologyresearchpioneeredbymultiomicsanalysisandmachinelearning
AT yoshitakanarita neweraofneurooncologyresearchpioneeredbymultiomicsanalysisandmachinelearning
AT ryujihamamoto neweraofneurooncologyresearchpioneeredbymultiomicsanalysisandmachinelearning